Visual Acuity Reduced Transiently Clinical Trial
— OPTicTRAINOfficial title:
Preliminary Evaluation of the Clinical Benefit of a Novel Visual Rehabilitation System in Patients Implanted With Trifocal Diffractive Intraocular Lenses: A Blinded Randomized Placebo-controlled Clinical Trial
Verified date | July 2021 |
Source | Increase-Tech |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This multicentre randomised controlled trial aimed to reduce the visual discomfort that patients implanted with trifocal diffractive intraocular lenses may experience after surgery. To this end, a visual training software (Optictrain) was developed in which Gabor patches were presented to the patient on a hand-held electronic device. Patients who met all inclusion criteria and consented to participate underwent half an hour of visual training per day for a period of 20 consecutive days remotely on a colourimetrically characterised Samsung Galaxy Tab A device on which the Optictrain software (n=30) or a placebo software (n=30), respectively, was pre-installed. Corrected and uncorrected near, intermediate and distance visual acuity (VA) and mesopic near and distance contrast sensitivity (CS) were measured monocularly and binocularly at two visits: during the first postoperative week (V0) and after 20 days of visual training with the assigned software (V1). The statistical analysis of the results obtained in the study has not yet been carried out.
Status | Completed |
Enrollment | 60 |
Est. completion date | July 20, 2021 |
Est. primary completion date | June 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Age between 18 an 90 years - Patients implanted with trifocal diffractive intraocular lenses - Availability and motivation to perform the visual training assigned Exclusion Criteria: - Age under 18 or over 90 years - Presence of irregular cornea, illiteracy or cognitive impairment - History of eye surgery or presence of any active ocular disease - Intraoperative complications leading to significant visual sequelae - Patients implanted with monofocal, extended depth of focus or refractive multifocal IOLs |
Country | Name | City | State |
---|---|---|---|
Spain | Faculty of Medicine, University of Valladolid | Valladolid |
Lead Sponsor | Collaborator |
---|---|
Increase-Tech | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA, Ministerio de Economía y Competitividad, Spain, University of Alicante |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual acuity | Monocular and binocular corrected and uncorrected visual acuity under near, intermediate and distance conditions | During the first post-operative week and after 20 days of vision training with the randomly assigned software | |
Primary | Contrast sensitivity | Monocular and binocular mesopic contrast sensitivity under near and distance conditions | During the first post-operative week and after 20 days of vision training with the randomly assigned software |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04703231 -
Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause
|
||
Completed |
NCT04724525 -
Changes in Power and Cylinder Axis of Toric Soft Contact Lenses (LKL)
|
N/A | |
Completed |
NCT01244334 -
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
|
Phase 4 | |
Terminated |
NCT03409185 -
The Incidence of Glistenings in the 2017 Intraocular Lenses Made by Alcon and Abbott Medical Optics
|
N/A | |
Terminated |
NCT02665689 -
Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
|
Phase 4 |